These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The Impact of Inflammatory Bowel Disease in Canada 2018: Children and Adolescents with IBD. Carroll MW; Kuenzig ME; Mack DR; Otley AR; Griffiths AM; Kaplan GG; Bernstein CN; Bitton A; Murthy SK; Nguyen GC; Lee K; Cooke-Lauder J; Benchimol EI J Can Assoc Gastroenterol; 2019 Feb; 2(Suppl 1):S49-S67. PubMed ID: 31294385 [TBL] [Abstract][Full Text] [Related]
4. Crohn's and Colitis Canada's 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Seniors With IBD. Bernstein CN; Singh H; Murthy SK; Nguyen GC; Benchimol EI; Bitton A; Kuenzig ME; Huang JG; Jones JL; Lee K; Targownik LE; Windsor JW; Mukhtar MS; Tandon P; Kaplan GG J Can Assoc Gastroenterol; 2021 Dec; 4(Suppl 2):S34-S39. PubMed ID: 34755037 [TBL] [Abstract][Full Text] [Related]
5. Crohn's and Colitis Canada's 2021 Impact of COVID-19 & Inflammatory Bowel Disease in Canada: A Knowledge Translation Strategy. Kaplan GG; Windsor JW; Crain J; Barrett L; Bernstein CN; Bitton A; Chauhan U; Coward S; Fowler S; Ghia JE; Gibson DL; Griffiths AM; Jones JL; Khanna R; Kuenzig ME; Lakatos PL; Lee K; Mack DR; Marshall JK; Mawani M; Murthy SK; Panaccione R; Seow CH; Targownik LE; Zelinsky S; Benchimol EI J Can Assoc Gastroenterol; 2021 Dec; 4(Suppl 2):S10-S19. PubMed ID: 34755034 [TBL] [Abstract][Full Text] [Related]
6. The Impact of Inflammatory Bowel Disease in Canada 2018: Direct Costs and Health Services Utilization. Kuenzig ME; Benchimol EI; Lee L; Targownik LE; Singh H; Kaplan GG; Bernstein CN; Bitton A; Nguyen GC; Lee K; Cooke-Lauder J; Murthy SK J Can Assoc Gastroenterol; 2019 Feb; 2(Suppl 1):S17-S33. PubMed ID: 31294382 [TBL] [Abstract][Full Text] [Related]
7. Crohn's and Colitis Canada's 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Mental Health and Quality of Life. Graff LA; Fowler S; Jones JL; Benchimol EI; Bitton A; Huang JG; Kuenzig ME; Kaplan GG; Lee K; Mukhtar MS; Tandon P; Targownik LE; Windsor JW; Bernstein CN J Can Assoc Gastroenterol; 2021 Dec; 4(Suppl 2):S46-S53. PubMed ID: 34755039 [TBL] [Abstract][Full Text] [Related]
8. Crohn's and Colitis Canada's 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Epidemiology-The Trends of Disease Over Time. Coward S; Windsor JW; Kuenzig ME; Bitton A; Bernstein CN; Jones JL; Khanna R; Lee K; Murthy SK; Targownik L; Benchimol E; Huang JG; Mukhtar MS; Tandon P; Kaplan GG J Can Assoc Gastroenterol; 2021 Dec; 4(Suppl 2):S20-S26. PubMed ID: 34755035 [TBL] [Abstract][Full Text] [Related]
9. Crohn's and Colitis Canada's 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Health Care Delivery During the Pandemic and the Future Model of Inflammatory Bowel Disease Care. Jones JL; Benchimol EI; Bernstein CN; Huang JG; Marshall JK; Mukhtar MS; Murthy SK; Nguyen GC; Kaplan GG; Kuenzig ME; Tandon P; Targownik LE; Windsor JW; Bitton A J Can Assoc Gastroenterol; 2021 Dec; 4(Suppl 2):S61-S67. PubMed ID: 34755041 [TBL] [Abstract][Full Text] [Related]
10. Crohn's and Colitis Canada's 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Risk Factors and Medications. Targownik LE; Bernstein CN; Lakatos PL; Murthy SK; Benchimol EI; Bitton A; Huang JG; Kuenzig ME; Jones JL; Kaplan GG; Lee K; Mukhtar MS; Tandon P; Windsor JW; Panaccione R J Can Assoc Gastroenterol; 2021 Dec; 4(Suppl 2):S40-S45. PubMed ID: 34755038 [TBL] [Abstract][Full Text] [Related]
11. Crohn's and Colitis Canada's 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: COVID-19 Vaccines-Biology, Current Evidence and Recommendations. Murthy SK; Kuenzig ME; Windsor JW; Ghia JE; Griffiths AM; Panaccione R; Seow CH; Benchimol EI; Bernstein CN; Bitton A; Huang JG; Jones JL; Lee K; Kaplan GG; Mukhtar MS; Tandon P; Targownik LE; Gibson DL J Can Assoc Gastroenterol; 2021 Dec; 4(Suppl 2):S54-S60. PubMed ID: 34755040 [TBL] [Abstract][Full Text] [Related]
12. The Impact of Inflammatory Bowel Disease in Canada 2018: Extra-intestinal Diseases in IBD. Bernstein CN; Benchimol EI; Bitton A; Murthy SK; Nguyen GC; Lee K; Cooke-Lauder J; Kaplan GG J Can Assoc Gastroenterol; 2019 Feb; 2(Suppl 1):S73-S80. PubMed ID: 31294387 [TBL] [Abstract][Full Text] [Related]
13. Severe Activity of Inflammatory Bowel Disease is a Risk Factor for Severe COVID-19. Macaluso FS; Giuliano A; Fries W; Viola A; Abbruzzese A; Cappello M; Giuffrida E; Carrozza L; Privitera AC; Magnano A; Ferracane C; Scalisi G; Minissale MG; Giangreco E; Garufi S; Bertolami C; Cucinotta U; Graziano F; Casà A; Renna S; Teresi G; Rizzuto G; Mannino M; Maida M; Orlando A Inflamm Bowel Dis; 2023 Feb; 29(2):217-221. PubMed ID: 35385102 [TBL] [Abstract][Full Text] [Related]
14. Impact of SARS-CoV-2 Vaccination on Inflammatory Bowel Disease Activity and Development of Vaccine-Related Adverse Events: Results From PREVENT-COVID. Weaver KN; Zhang X; Dai X; Watkins R; Adler J; Dubinsky MC; Kastl A; Bousvaros A; Strople JA; Cross RK; Higgins PDR; Ungaro RC; Bewtra M; Bellaguarda E; Farraye FA; Boccieri ME; Firestine A; Kappelman MD; Long MD Inflamm Bowel Dis; 2022 Oct; 28(10):1497-1505. PubMed ID: 34871388 [TBL] [Abstract][Full Text] [Related]
15. Effect of anti-SARS-CoV-2 BNT162b2 mRNA vaccination on thrombin generation in children with inflammatory bowel disease. Stercel V; Lóczi L; Kadenczki O; Nemes É; Nagy B; Hodossy-Takács R; Szabó AÁ; Fagyas M; Kappelmayer J; Szabó T; Bagoly Z Front Immunol; 2023; 14():1257072. PubMed ID: 37965328 [TBL] [Abstract][Full Text] [Related]
16. COVID-19 Pandemic's Effects on Disease and Psychological Outcomes of People With Inflammatory Bowel Disease in Portugal: A Preliminary Research. Trindade IA; Ferreira NB Inflamm Bowel Dis; 2021 Jul; 27(8):1224-1229. PubMed ID: 33043977 [TBL] [Abstract][Full Text] [Related]
17. Recent advances in clinical practice: management of inflammatory bowel disease during the COVID-19 pandemic. Lin S; Lau LH; Chanchlani N; Kennedy NA; Ng SC Gut; 2022 Jul; 71(7):1426-1439. PubMed ID: 35477864 [TBL] [Abstract][Full Text] [Related]
18. Inflammatory bowel disease amid the COVID-19 pandemic: impact, management strategies, and lessons learned. Gajendran M; Perisetti A; Aziz M; Raghavapuram S; Bansal P; Tharian B; Goyal H Ann Gastroenterol; 2020; 33(6):591-602. PubMed ID: 33162736 [TBL] [Abstract][Full Text] [Related]
19. Impact of the coronavirus infectious disease (COVID-19) pandemic on the provision of inflammatory bowel disease (IBD) antenatal care and outcomes of pregnancies in women with IBD. Selinger CP; Fraser A; Collins P; Gunn M; Chew TS; Kerry G; Patel KV; Roysam M; Bel Kok K; Bancil A; Hall V; Cooney R; Smith L; Steed H; Segal J; Kent A; Limdi J; Sebastian S BMJ Open Gastroenterol; 2021 Mar; 8(1):. PubMed ID: 33753426 [TBL] [Abstract][Full Text] [Related]
20. COVID-19 Pandemic: Which IBD Patients Need to Be Scoped-Who Gets Scoped Now, Who Can Wait, and how to Resume to Normal. Ng SC; Mak JWY; Hitz L; Chowers Y; Bernstein CN; Silverberg MS J Crohns Colitis; 2020 Oct; 14(14 Suppl 3):S791-S797. PubMed ID: 33085973 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]